By Bilal Hafeez 22-12-2020

Ep. 44: Michael Auerbach On Launching A Cannabis SPAC With Jay-Z

(1 min read)
Resize text:


Michael Auerbach is the Founder of Subversive Capital, which is dedicated to investing in radical companies. He sits on the Board of Directors of Tilray, Inc. – the first Nasdaq-listed global cannabis company – and holds several directorships with companies that Subversive invests in. He also serves as a Senior Vice President at Albright Stonebridge Group, the global consulting firm chaired by former Secretary of State, Madeleine Albright. In this podcast, we discuss: 

  1. Launching a SPAC (SBVCF) with Jay-Z for the cannabis sector 
  2. The bullish case for the California cannabis market 
  3. Why Canada’s legalization of cannabis has still seen illicit trade increase 
  4. The financing challenge for cannabis companies 
  5. Why brands are where the value is 
  6. How the Biden administration will accelerate legalisation 
  7. The political and cultural reasons for banning cannabis over alcohol 
  8. The Portugal case of decriminalisation 
  9. Books that influenced Michael: Far From the Tree (Solomon), How to Change Your Mind (Pollan), Sapiens (Harari), History of Sexuality (Foucault), Glas (Derrida), King Leopold’s Ghost (Hochschild), Malcolm X, Say Nothing (Keefe)  

Details of the Subversive SPAC (SBVCF) can be found here. You can follow Michael on Twitter here 

Make sure to subscribe to the show on AppleSpotify, YouTube, or wherever you go for your podcasts. You can follow us on Twitter and LinkedIn.



(The commentary contained in the above article does not constitute an offer or a solicitation, or a recommendation to implement or liquidate an investment or to carry out any other transaction. It should not be used as a basis for any investment decision or other decision. Any investment decision should be based on appropriate professional advice specific to your needs.)



For access to our Slack Chat Room, where we discuss all things markets with our researchers and subscribers



ECB Preview: Biding Time Until June (2 min read)

By Caroline Grady | Apr 20, 2021
Stepped up PEPP purchases since the 11 March ECB meeting leave little need for any policy changes at this week’s governing council meeting...

Russia Sanctions: The Shock That Never Came (5 min read)

By Tatiana Orlova | Apr 16, 2021
The most important measure bars US entities from newly issued local sovereign debt, effective from 14 June. The ban includes debt issued by the CBR...

Weekly Vaccination Update: J&J Pause and EU Supply Schedule (1 min read)

By Sam van de Schootbrugge | Apr 14, 2021
In this prime tracker, we review the latest vaccine developments globally. This week, we’ve added some brief commentary...


ECB Preview: Biding Time Until June (2 min read)

By Caroline Grady | Apr 20, 2021
Summary Thursday’s ECB meeting is unlikely to…

Five Things You Did Not Know About China (2 min read)

By Bilal Hafeez | Apr 13, 2021
China is a global economic superpower, yet…

Want To Join Our Community Of Leading Investors And Researchers In Our Slack Chat Room?